Justin Li
About Justin Li
Justin Li is a Medical Science Manager at BeiGene in Hong Kong SAR with extensive experience in medical affairs and sales roles across various pharmaceutical companies.
Current Role at BeiGene
Justin Li is currently employed as a Medical Science Manager at BeiGene in the Hong Kong SAR. In this role, he engages in medical science initiatives and activities to support the company's objectives in the region. His expertise in medical affairs, combined with his extensive experience in the pharmaceutical industry, contributes to BeiGene's mission and goals.
Professional Experience at Merck Hong Kong
Prior to his current role, Justin Li worked at Merck Hong Kong in various capacities. From 2022 to 2023, he served as a Medical Affairs Manager for nine months. Before this, he was a Medical Science Liaison from 2020 to 2022. In these roles, he managed medical affairs and liaised with stakeholders to ensure the effective communication of scientific data and support for Merck's products.
Career Beginnings at Sanofi
Justin Li launched his career at Sanofi, where he held multiple positions. He started as a Sales Executive from 2018 to 2019, eventually transitioning to a Medical Associate in the Diabetes division from 2019 to 2020. These positions allowed him to develop a strong foundation in both sales and medical affairs within the pharmaceutical industry.
Internships and Early Experience
Justin Li has a diverse background of internships and volunteer work, bolstering his hands-on experience in the field. He interned at Pfizer and Queen Mary Hospital in 2017 and 2018, respectively, gaining valuable clinical insights. He also completed an industrial placement at GSK in 2016, and a short-term placement with Sanofi in 2014. His early volunteer work at the Chief Pharmacist's Office and Queen Mary Hospital further highlights his commitment to healthcare.
Educational Background
Justin Li is advancing his education with an MBA from HKU Business School, which he started in 2023 and is expected to complete in 2025. He previously earned a Bachelor of Pharmacy degree from The Chinese University of Hong Kong, where he studied from 2013 to 2017. Additionally, he holds an International Baccalaureate Diploma from Upper Canada College, which he obtained between 2010 and 2013.